The use of Assisted Reproductive Technology (ART), which includes in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) has more than doubled in the U.S. over the past decade¹. Factors leading to this increase may include:

• A better understanding, awareness and acceptance about infertility²
• An increase in planned oocyte cryopreservation (i.e., egg freezing)³
• LGBTQ+ couples and individuals using ART to build their families⁴
• An increase in employers offering fertility benefits⁵
• The shift towards women having children later in life⁶

At Ferring, we help build families. For more than 50 years, Ferring has been at the forefront of innovation in reproductive medicine because we understand everyone’s path to parenthood is unique. From offering a portfolio of treatment options, to advocating for increased awareness and access to fertility care, to developing new educational resources, we’re committed to supporting diverse family-building needs and fertility journeys. We’re focused on helping the 1 in 6 people worldwide⁷ who have infertility as well as the many aspiring parents who use ART to start or grow their families.